Physician profile
Rustico A Ramos
NPI 1730166505
$806.22
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $28.03 · 2021: $111 · 2023: $48.36 · 2024: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $190.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $256.82 | 2019-2020 | |
| Abbvie INC. | $134.31 | 2021-2023 | |
| Medtronic, INC. | $129.20 | 2024 | Intellis Adaptivestim |
| Sunovion Pharmaceuticals INC. | $50.34 | 2019 | |
| Amgen INC. | $37.47 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.32 | 2019 | |
| Lilly USA, LLC | $26.45 | 2019 | |
| Orexo US, INC. | $25.10 | 2021 | |
| Novartis Pharmaceuticals Corporation | $22.22 | 2019 | |
| Indivior INC. | $19.63 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.42 | 2019 | |
| Boston Scientific Corporation | $14.58 | 2019 | |
| Merck Sharp & Dohme LLC | $13.30 | 2024 | Capvaxive, Gardasil, Gardasil 9 |
| Glaxosmithkline, LLC. | $12.51 | 2019 | |
| Amarin Pharma, INC. | $11.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rustico Ramos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.